Lunsekimig Evidence: Trial Results and Peer-Reviewed Publications
Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated:
The clinical evidence base for Lunsekimig comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Asthma. Most recent publication: Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma., Ann Allergy Asthma Immunol, 2025.
Top peer-reviewed publications
Curated set of pivotal-trial result papers and recent publications in high-tier journals.
- Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.Seluk L, Davis AE, Rhoads S, et al. · Ann Allergy Asthma Immunol · 2025
Publications by year
2025–2025: 1 publications.
2025
1
Publications by indication
Asthma (1)
- Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.
Publications by journal
- Ann Allergy Asthma Immunol1 paper
All Lunsekimig publications (1)
2025 (1 paper)
- Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma.Seluk L, Davis AE, Rhoads S, et al. · Ann Allergy Asthma Immunol · 2025 · Derived
Sources and methodology
- Publications:
ctgov.study_references(PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference typesRESULT,DERIVED, andBACKGROUND. - Per-arm outcome values:
ctgov.outcome_measurementsjoined toctgov.design_outcomeswhereoutcome_type = 'PRIMARY', restricted to phasePHASE3andPHASE2/PHASE3. - Publication metadata (title, journal, year, authors): PubMed E-utilities
efetch.fcgi - Data freshness: Tue, 02 Jun 2026 17:27:09 GMT.
This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).